Helsinki

• CHIP-AML22 Master protocol: Protocol for the treatment of children and adolescents with Acute Myeloid Leukemia (AML) Recruiting
  2023-504999-25-00 5 2023-07-14 Acute Myeloid Leukemia
• Tranexamic acid for hyperacute spontaneous IntraCerebral Haemorrhage (TICH-3) Recruiting
  2022-500587-35-01 5 2023-07-06 Stroke
• A Study of Subcutaneous Nivolumab + Relatlimab FDC in Previously Untreated Metastatic or Unresectable Melanoma (RELATIVITY-127) Recruiting
  2022-500967-11-00 5 2023-07-06 Previously Untreated Metastatic or Unresectable Melanoma
• AttaCH: A Phase 2, Multicenter, Long-Term, Open Label Extension Trial Evaluating Safety, Tolerability, and Efficacy of Subcutaneous Doses of … Recruiting
  2022-502202-33-00 4 2023-07-06 Achondroplasia in Children and Adolescents
• Desensitisation with imlifidase prior to kidney transplant in highly sensitised children Recruiting
  2022-500230-28-00 4 2023-06-02 Highly sensitised paediatric patients with a positive crossmatch again
• SACK Recruiting
  2022-501600-10-00 5 2023-02-07 Atrial fibrillation and Chronic Kidney Disease stage 5
• KF2022#1 trial: The effect of fecal microbiota transplantation on CYP enzyme activities Recruiting
  2024-518312-40-00 3 2023-01-05 Irritable bowel syndrome
• MagnetisMM-6: A Phase 3 Study of Elranatamab (PF-06863135) + Daratumumab + Lenalidomide Versus Daratumumab + Bortezomib + Lenalidomide + Dex … Recruiting
  2024-514139-50-00 5 2022-11-14 Multiple myeloma
• A study to learn more about how safe the study treatment finerenone is in long-term use when taken with an ACE inhibitor or angiotensin rece … Recruiting
  2023-504885-50-00 5 2022-11-07 Treatment of children with chronic kidney disease and proteinuria
• International Euro Ewing (iEuroEwing) trial for treatment optimisation in patients with Ewing sarcoma Recruiting
  2022-501180-40-00 5 2022-06-17 Ewing Sarcoma
• Studying Conditioning Regimen In Pediatric Transplantation -AML Recruiting
  2023-505512-37-00 5 2022-06-07 Acute Myeoloid Leukemia
• Brigatinib in pediatric and young adult patients with ALK+ ALCL, IMT or other solid tumors (Briga-PED) Recruiting
  2024-513412-10-00 9 2022-05-11 Anaplastic Large Cell Lymphoma (ALCL)
• EPO-TRAUMA Recruiting
  2023-506081-31-00 5 2022-03-29 Traumatic Injury
• Selatogrel Outcome Study in Suspected Acute Myocardial Infarction Recruiting
  2023-505438-85-00 5 2022-01-12 Acute myocardial infarction (AMI)
• SIOP-HRMB: An international prospective trial on clinically high-risk medulloblastoma (HR-MB) in patients older than 3 years. Recruiting
  2024-510578-25-00 5 2021-11-05 Histologically proven high-risk medulloblastoma, with any of the curre
• NMDSG-14B2 Recruiting
  2024-511651-17-00 4 2021-09-21 Myelodysplastic syndrome
• Phase 2 Study of Adagrasib Monotherapy and in Combination With Pembrolizumab and Phase 3 Study of Adagrasib in Combination with Pembrolizuma … Recruiting
  2023-508922-83-00 10 2021-03-17 Advanced Non-Small Cell Lung Cancer
• FaR-RMS: An overarching study for children and adults with Frontline and Relapsed RhabdoMyoSarcoma Recruiting
  2024-510579-40-00 9 2020-10-07 Rhabdoyosarcoma
• An international trial for children with atypical teratoid/rhabdoid tumours (ATRT) Recruiting
  2022-501456-28-00 5 2020-07-20 atypical teratoid/rhabdoid tumours (ATRT)
• A Treatment Study Protocol for Participants 0-45 Years With Acute Lymphoblastic Leukaemia Recruiting
  2022-501050-11-01 10 2020-07-13 Acute Lymphoblastic Leukaemia
• International study for children and adolescents with standard risk ALK-positive anaplastic large cell lymphoma (ALCL) estimating the effica … Recruiting
  2022-501454-11-00 5 2020-02-05 standard risk ALK-positive anaplastic large cell lymphoma (ALCL)
• An international investigator initiated trial to capture different approaches in the treatment of Haemophilia A Patients With FVIII Inhibito … Recruiting
  2024-516741-39-00 6 2020-01-14 Haemophilia A
• Study of two doses of crizanlizumab versus placebo in adolescent and adult sickle cell disease patients Recruiting
  2023-508689-14-00 5 2019-09-16 Sickle cell disease
• Impact of atorvastatin on prostate cancer progression after initiation of androgen deprivation therapy Recruiting
  2024-517854-91-00 5 2019-08-05 Metastatic or high-risk recurrent prostate cancer managed with androge

Showing 169–192 of 374 trials